Table 2. Associations between 25-hydroxyvitamin D (25(OH)D) level and patients with narcolepsy-cataplexy.
Normal controls N = 55 | Narcolepsy with cataplexy N = 51 | |||||||
n | % | n | % | OR [95%CI] | p-value * | OR [95%CI] ** | p-value ** | |
25(OH)D, nmol/L 1 | ||||||||
<45.9 | 8 | 14.55 | 19 | 37.25 | 5.34 [1.65–17.27] | 0.0023 | 3.63 [1.06–12.46] | 0.0191 |
[45.9–70.4[ | 12 | 21.82 | 14 | 27.45 | 2.63 [0.84–8.17] | 2.43 [0.76–7.77] | ||
[70.4–89.3[ | 17 | 30.91 | 10 | 19.61 | 1.32 [0.42–4.15] | 1.19 [0.37–3.85] | ||
≥89.3 | 18 | 32.73 | 8 | 15.69 | 1 | 1 |
Quartile of the whole population.
*For variables with more than two categories, the p-value of the test for trend is given.
**Adjustment for BMI on two classes (<25 and ≥25 kg/m2).